ExThera Medical develops blood filtration technologies, specifically the Seraph® 100 Microbind® Affinity Blood Filter for treating severe COVID-19 and the ONCObind™ Extracorporeal Procedure for treating metastatic cancer.

ExThera Medical

Deltex Medical Group plc, together with its subsidiaries, manufactures, markets, and sells oesophageal doppler haemodynamic monitoring systems under the TrueVue name in the United Kingdom, the United States, Spain, Canada, and internationally. It offers esophageal Doppler Probes that is used to measure a patient's central vascular blood flow and fluid status to measure real time blood velocities within the descending aorta; Loops plots aortic blood flow velocity and aortic blood pressure monitoring throughout every heartbeat; High Definition Impedance Cardiography, a non-invasive cardiac function and fluid status monitoring system for awake patients; and PressureWave, a pulse pressure waveform analysis algorithm used during periods of instability or for periods when the ODM mode is unavailable. The company also provides Deltex Medical Esophageal Doppler Simulator that enables clinicians to practice probe insertion, focusing, and waveform interpretation outside of a patient setting. Its products are used in Covid-19 critical care; sepsis; major abdominal, laparoscopic, and spinal surgeries; cardiac, trauma, and transplant procedures; and post-operative acute kidney injury monitoring. Deltex Medical Group plc was incorporated in 2000 and is headquartered in Chichester, the United Kingdom.

Deltex Medical Group plc

Leuko is developing PointCheck™, a device for non-invasive white cell monitoring, designed for use at home to evaluate white blood cell levels without a blood draw. This device aims to benefit immunosuppressed patients by providing frequent testing.

Leuko

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.

Metric
Company Name	ExThera Medical	Deltex Medical Group plc	Leuko	Medistim ASA
Symbol		DEMG		0OCD
MSH ID	COM:EXTHERAMEDICAL	COM:DELTEXMEDICAL	COM:LEUKO	COM:MEDISTIM
Market	PRIVATE	STOCKS	PRIVATE	STOCKS
Sector	Healthcare & Health Services	Healthcare	Healthcare & Health Services	Healthcare
Industry	Medical Devices	Medical - Devices	Medical Devices	Medical - Equipment & Services
Country	US	GB	US	NO
Stage
Employee Count		37		150
Website	extheramedical.com	deltexmedical.com	leuko.com	medistim.com
LinkedIn
Founders

Metric
Market Cap	35.04K	287.67M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	2.26M	47.24M
Revenue (LTM)
Revenue (NTM)
Gross Profit	1.40M	20.45M
EBITDA	-923.81K	13.92M
Operating Income	-1.09M	11.80M
Net Income	-1.60M	9.32M
EPS	-0.00	0.51
Diluted EPS	-0.00	0.51
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.70	0.59
Operating Profit Margin	-0.40	0.25
EBITDA Margin	-0.41	0.29
Net Profit Margin	-0.43	0.20
Return on Equity	-0.42	0.27
Return on Assets	-0.17	0.21
Return on Capital Employed	-0.16	0.32

COM:EXTHERAMEDICAL

ExThera Medical

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-0.90	33.21
P/B Ratio	0.44	10.29
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	1.71	6.30
EV Multiple	0.00	22.46

Metric
Days Sales Outstanding	77.65	56.28
Days Payables Outstanding	967.28	120.71
Days Inventory Outstanding	424.80	264.89
Operating Cycle	500.62	324.42
Cash Conversion Cycle	349.42	324.42
Asset Turnover	0.40	1.04

Metric
Operating Cash Flow	-1.52M	10.40M
Free Cash Flow	-1.99M	10.40M
Cash Flow to Debt	-0.12	16.22
Operating Cash Flow/Sales	-0.11	0.26
Free Cash Flow Yield	-0.47	0.02

Metric
Cash & Equivalents	898.33K	13.81M
Accounts Receivable	423.04K
Inventory	912.34K	13.05M
Goodwill
Debt to Capitalization	0.53	0.04
Debt to Assets	0.32
Current Ratio	0.75	4.05
Quick Ratio	1.13	2.99

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.05
R&D to Revenue	0.09	0.04
SG&A to Revenue	0.63	0.05